Novartis Seen Gaining as Merck Scraps MS Drug - June 22, 2011

Having trouble viewing this email? View in Browser.

Wednesday, June 22, 2011  |   |   |  Reduce Risk and Maximize Potential in Ophthalmology Development: Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development. The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA +1-713-559-7900, UK +44-0-1344-891121. •  Merck KGaA (MKGAF.PK) Pulls Plug on Cladribine on FDA Feedback More... •  High-Dose Statins Like Pfizer Inc. (PFE)'s Lipitor and Merck & Co., Inc. (MRK)'s Zocor Raise Risk of Diabetes More... More Discontinuations News More Recalls and Warning News •  Fibrocell Science, Inc. Announces FDA Approval for laViv(R) (azficel-T) More... •  ProStrakan Group Receives FDA Approval for Rectiv(TM) for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures More... More Drug Approval News •  FDA Panel Rejects Novartis AG Drug for Gout More... •  Ligand Pharmaceuticals Inc. (LGND) to Advance Clinical Development of Captisol-enabled(R)phase, Propylene Glycol-Free Melphalan for Multiple Myeloma More... •  22nd Century Files Investigational New Drug Application and Fast Track Request for X-22; Phase II-B Clinical Trial to Commence Immediately Upon FDA Clearance More... •  Ventrus Biosciences, Inc.  (VTUS) Receives SPA Response From FDA and Will Update and File the First Pivotal Trial Protocol to its IND More... More BLA/NDA/ANDA News More IND News More MAA News •  Lipid Therapeutics Announces Positive Topline Phase IIb Results With LT-02 in Patients With Ulcerative Colitis More... •  Tobira Therapeutics Inc. Initiates Phase IIb Trial of Cenicriviroc, a Novel CCR5/CCR2 Antagonist for the Treatment of HIV Infection More... •  Endotis Pharma Intiates Phase IIa Study of First-in-Class Neutralizable Anticoagulant in Open-Heart Surgery More... •  Infinity Pharmaceuticals Inc. (INFI) Expands Clinical Development Program for IPI-926, an Oral Smoothened Antagonist Targeting the Hedgehog Pathway More... •  Ritter Pharmaceuticals, Inc. Announces First Patient Enrollment in Its Phase 2 Clinical Study of RP-G28 for the Treatment of Lactose Intolerance More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  Rheumatoid Arthritis Drugs May Help Curb Diabetes Development, Journal of the American Medical AssociationStudy Finds More... •  First Genetic Mutation Linked to Heart Failure in Pregnant Women, Intermountain Medical Center Heart Institute Study More... •  Strawberries Boost Red Blood Cells, Marche Polytechnic University and University of Granada Study Finds More... •  Pine Bark Naturally Improves Heart Function, Study in Panminerva Medica More... •  Obagi Medical Products, Inc. (OMPI) Introduces New Clinical Data Showing Combination of Hydroquinone Skin Care System and Tretinoin May Reduce Melasma Severity in Patients with Darker Skin More... More General Clinical Research News Just Released: IBC's BioProcess International Conference Brochure Download your copy today at: www.ibclifesciences.com/bpi/brochure.xml BioProcess International Conference & Exhibition October 31 - November 4, 2011: Long Beach, California This conference is where challenges are explored, solutions are uncovered and opportunities are developed, making it the largest and most highly respected event solely dedicated to biopharmaceutical manufacturing. BioProcess International is your one stop industry resource for driving down costs, improving quality, achieving rapid, robust and resilient process development and manufacturing. Register today at www.IBCLifeSciences.com/BPI/register.xml or call 800-390-4078. Advances in Drug-Diagnostic Co-Development • Understand the current regulatory environment for both diagnostics and drugs within the EU and the US and how these relate to their co-development. • Understand the biomarker discovery and validation process. • Using case studies discover how drugs and their companion diagnostics have already received approval in the US and EU. Click Here for More Information • Biotech Bay (South San Francisco, California) Exelixis, Inc. Sr. Clinical Trials Manager Accountable for the day-to-day management of operations of 1-4 clinical trials commensurate with complexity, including trial start-up, conduct, and close-out activities. This activity is coordinated in conjunction with one or more CROs. • BioCapital (Rockville, Maryland) Human Genome Sciences, Inc. Clinical Trial Manager Responsible for study start up activities, including assisting with investigator recruitment, site feasibility, vendor selection (CRO, Central Laboratory, etc.), CRF development, edit specifications, procurement of clinical trial insurance, collection of regulatory documents, etc. • Pharm Country (Ridgefield, Connecticut) Boehringer Ingelheim Pharmaceuticals, Inc. Director, Clinical Research (MD) - Diabetes You will ensure that goals and objectives for a drug development program are met. Provides medical/scientific and technical direction to the planning, implementation, conduct, completion, etc. • Biotech Beach (Irvine, California) Allergan Inc. Clinical Study Specialist Develops, evaluates, and executes all essential clinical trial documents and clinical trial agreements (CTAs). Aligns execution activities with agreed upon project priorities, timings and quality specifications. Etc. • BioMidwest (Indianapolis, Indiana) Eli Lilly and Company Principal Research Scientist, Immunologist - Autoimmune Disease Serve as a source of state-of-the-art scientific knowledge in the field of immuno-inflammation especially as this applies to autoimmune disease; exert influence on research direction and the choice of experimental approaches taken. Etc. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! BIO Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Washington, DC area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • BIO Career Fair, Washington DC, June 27, 2011 • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Pharmasset, Inc. (VRUS) Announces Issuance of U.S. Patent for PSI-7977 More... More Patent News •  Abbott Laboratories (ABT) Plans Changes to Humira to Thwart Competition More... •  Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Levofloxacin Tablets More... •  Biogen Idec, Inc. (Massachusetts) (BIIB) and Elan Corporation PLC (ELN) Release: European Commission (EC) Approves Inclusion of Anti-JC Virus Antibody Status as a PML Risk Factor in TYSABRI Labeling More... •  AMAG Pharmaceuticals, Inc. (AMAG) Announces Update to Feraheme(R) Label More... •  Oxford BioMedica PLC (OXB.L) Announces Ocular Programme Update More... More Drug Product News Hot Company Accelovance 2275 Research Boulevard, Suite 700 Rockville, Maryland 20850 U.S.A. Phone: 240-238-4900 Fax: 240-238-4901 Accelovance, based in Rockville, MD, is a clinical services company specializing in high patient throughput from recruitment through study completion. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Matt Thwin, Maysa Darwish ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the ClinicaSpace Focus here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.